Bioassay-directed fractionation of the methyl ethyl ketone extract of
Chiloscyphus rivularis yielded five new sesquiterpenes, 12-hydroxychil
oscyphone (2), chiloscypha-2,7-dione (3), 12-hydroxychiloscypha-2,7-di
one (4), chiloscypha-2,7,9-trione (5), and rivulalactone (6) in additi
on to the known sesquiterpenes, 4-hydroxyoppositan-7-one (7), chiloscy
phone (1), and isointermedeol (8). The structure and stereochemistry o
f rivulalactone, a novel trinorsesquiterpene, was confirmed by its syn
thesis starting from 1. Compound 2 showed selective bioactivity in our
yeast-based DNA-damaging assay and cytotoxicity to human lung carcino
ma cells.